Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Simple item page
dc.contributor.authorAdra, Nabil
dc.contributor.authorCheng, Liang
dc.contributor.authorPili, Roberto
dc.contributor.departmentDepartment of Medicine, School of Medicineen_US
dc.date.accessioned2017-10-06T16:59:45Z
dc.date.available2017-10-06T16:59:45Z
dc.date.issued2017-06
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationAdra, N., Cheng, L., & Pili, R. (2017). Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab. Clinical genitourinary cancer, 15(3), e517. https://doi.org/10.1016/j.clgc.2016.12.019en_US
dc.identifier.urihttps://hdl.handle.net/1805/14271
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.clgc.2016.12.019en_US
dc.relation.journalClinical Genitourinary Canceren_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectimmunotherapyen_US
dc.subjectkidney canceren_US
dc.subjecttherapeuticen_US
dc.titleUnclassified Renal Cell Carcinoma With Significant Response to Nivolumaben_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Adra_2017_unclassified.pdf
Size:
744.11 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works